First Shots Given in Trial of Moderna mRNA-Based HIV Vaccine
Vaccine uses mRNA technology to deliver HIV-specific antigens that could trigger an immune response against the virus
California Universal Health Care System Bill Faces Monday Deadline
There is also a second bill to fund universal health care, which has a different deadline and does not have to pass on Monday
FDA Gives Moderna COVID-19 Vaccine Full Approval
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax
Long-Acting Cabotegravir Not Necessarily Cost-Effective for PrEP
Benefits do not necessarily justify large price difference compared with generic F/TDF for men who have sex with men and transgender women
‘Stealth’ Version of Omicron Variant No Cause for Alarm, Experts Say
New version of the variant does not appear to cause more severe disease, and vaccines are effective against it
CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis
Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met
Remdesivir May Benefit Adults Early in COVID-19 Course
Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen
4.95 Million Deaths Linked to Antimicrobial Resistance in 2019
Lower respiratory infections accounted for >1.5 million deaths associated with resistance, making it the most burdensome syndrome
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Neutralization Titers Against Omicron Up With mRNA-1273 Boost
After mRNA-1273 boost, neutralization titers against the omicron variant 20.0 times higher than than those at one month after second dose
